health

Statins reduce cancer risk by up to 40 percent among heart failure patients, says study


are a group of medicines that can help lower the level of low-density lipoprotein (LDL) cholesterol in the blood. LDL cholesterol is often called the “bad” cholesterol because it collects in the walls of your blood vessels, hiking your risk of having a heart attack. Fortunately, statins intercept this process by reducing the production of LDL cholesterol inside the liver. Another major benefit of taking the drug is its ability to reduce cancer risk, says a new study.

Lead researcher Dr Kai-Hang Yiu said: “Our findings should raise doctors’ awareness of the increasing cancer incidence among patients and encourage them to pay extra attention to non-cardiovascular-related outcomes.

“Moreover, our study highlights the relationship between heart failure and cancer development and provides important information regarding the possibility of reducing cancer incidence and related deaths by using statins in these patients.

“Randomised trials should be carried out to investigate this further.

“In addition, the findings, combined with previous research showing the strong association between heart failure and cancer, call for potential strategies to reduce the risk of cancer, such as screening for cancer in heart failure patients.”

Previous laboratory studies have suggested that lipids including cholesterol play a role in the development of cancer, and that statins inhibit cancer development, said lead author Paul Carter, Cardiology Academic Clinical Fellow at the Department of Health and Primary Care, University of Cambridge, UK.

He added: “However, no trials have been designed to assess the role of statins for cancer prevention in clinical practice.

“We decided to assess the potential effect of statin therapy on cancer risk using evidence from human genetics.”

See also  Stomach bloating: Take this herbal supplement to restore your gut health

In a previous study, genetic variants which mimic the effect of statins through a technique known as Mendelian randomisation in UK Biobank was further analysed.

UK Biobank is a large study of UK residents which tracks the diagnosis and treatment of many serious illnesses.

Researchers were able to compare the risk of cancer in patients who inherit a genetic predisposition to high or low levels of cholesterol and were able to predict whether by lowering one’s cholesterol levels could their cancer risk be reduced too.





READ SOURCE

Leave a Reply

This website uses cookies. By continuing to use this site, you accept our use of cookies.  Learn more